Craft

Endomag

Revenue

£18.3 M

FY, 2022

Endomag Summary

Company Summary

Overview
Endomag (also known as Endomagnetics) is a medical technology company that develops technologies for breast cancer surgery. It offers Sentimag, a surgical guidance system for ultrasensitive detection in pre-and post-incision use; Magseed, a sterile biocompatible seed containing magnetic material placed near the tumor before surgery; Magtrace, an injectable liquid tracer containing magnetic particles used to identify and map lymphatic drainage basins; etc.
Type
Subsidiary
Status
Active
Founded
2007
HQ
Cambridge, GB | view all locations
Website
https://www.endomag.com
Cybersecurity rating
Sectors

Key People

  • Eric Mayes

    Eric Mayes, Chief Executive Officer and Director

  • Andrew Shawcross

    Andrew Shawcross, Chief Operating Officer

  • Quentin Harmer

    Quentin Harmer, Chief Technology Officer

  • Mathew Stephens

    Mathew Stephens, Chief Marketing Officer

Operating MetricsView all

Patients Served to Date

485K
203.1%

May, 2024

Trademarks

79
7800.0%

May, 2024

Countries

45
12.5%

May, 2024

LocationsView all

3 locations detected

  • Cambridge, England HQ

    United Kingdom

    330 Cambridge Science Park Milton Rd

  • Austin, TX

    United States

    1701 Trinity St

  • Wilmington, DE

    United States

    251 Little Falls Drive

Endomag Financials

Summary Financials

Revenue (FY, 2022)
£18.3M
Gross profit (FY, 2022)
£13.2M
Net income (FY, 2022)
(£4.1M)
Cash (FY, 2022)
£7.8M
EBIT (FY, 2022)
(£4.9M)

Footer menu